Analgesia

  • Design Considerations for Single-Dose Analgesia Trials in Acute Pain: Recommendations from the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials
  • Developing Analgesia Studies: Use of Placebo Control in the EU
  • Designed Especially For Kids Writing Protocols for Pediatric Analgesia Clinical Trials of Acute Pain
  • Hematology/Oncology

  • Rapid Change, Real Promise: The Future of Rare Oncology Research
  • Maximizing Success in Early Stage Oncology Trials
  • Medical Device and Diagnostics

  • Applying Sound Research Practices in the Development of Medical Devices
  • Clinical Endpoint Committees: Ensuring the Quality, Validity, and Integrity of Clinical Trial Results
  • Neuroscience

  • Measuring How Well Subjects Know and Do in CNS Trials
  • Strategies for Collecting Quality Data in Psychiatric Clinical Trials
  • Pediatrics

  • Involving Children, Adolescents, and Parents in Pediatric Drug Development
  • The Science and Art of Conducting Clinical Trial Feasibility in Rare Disease and Pediatric Studies
  • Designed Especially For Kids Writing Protocols for Pediatric Analgesia Clinical Trials of Acute Pain
  • Rare Disease

  • Applying Quality by Design to the Rare Disease Population
  • Clinical Trials in Rare Diseases: Every Patient Counts
  • Orphan Drug and Rare Disease Development: Understanding the U.S. and European Regulatory Landscape
  • Proven Strategies for Rare Disease and Orphan Drug Development in the U.S.
  • The Science and Art of Conducting Clinical Trial Feasibility in Rare Disease and Pediatric Studies
  • The Science of Hope: The need, the challenges, and three proven strategies for successful orphan drug development
  • Fit-For-Purpose: A Strategic Approach to Biomarker Method Validation for Rare Disease
  • Regulatory

  • Navigating Expedited Regulatory Pathways in the U.S. and Europe
  • Orphan Drug and Rare Disease Development: Understanding the U.S. and European Regulatory Landscape
  • Resources

  • Applying Sound Research Practices in the Development of Medical Devices
  • Uncategorized

  • A Delayed Onset Muscle Soreness (DOMS) Model for the Evaluation of Topical Analgesics Michael Kuss, Vice President, Analgesia, Strategic Development. Presented at the 9th Congress of the European Pain Federation. Kuss explores ways to minimize variability in pain studies and examines methods for increasing the chances of demonstrating a medication’s therapeutic effect.